Bristol-Myers Squibb Company
Bristol-Myers Squibb Company (0R1F.L) Stock Competitors & Peer Comparison
See (0R1F.L) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - General Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| 0R1F.L | £72.70 | +0.00% | 118.7B | 25.75 | £2.82 | +3.38% |
| 0QCV.L | £146.95 | +0.00% | 221B | 21.08 | £6.97 | +4.40% |
| 0QAH.L | £80.07 | +0.17% | 201.1B | 11.64 | £6.88 | +3.99% |
| 0QQ6.L | £258.80 | +0.15% | 198.7B | 15.98 | £16.20 | +3.94% |
| AZN.L | £11,086.00 | +0.45% | 171.9B | 28.14 | £3.94 | +1.89% |
| GSK.L | £1,404.50 | +0.04% | 56.7B | 16.92 | £0.83 | +4.11% |
| DPH.L | £3,866.00 | +0.05% | 4.4B | -154.64 | -£0.25 | N/A |
| VEC.L | £164.80 | +0.00% | 0 | 0.08 | £20.10 | N/A |
Stock Comparison
0R1F.L vs 0QCV.L Comparison August 2025
0R1F.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, 0R1F.L stands at 118.7B. In comparison, 0QCV.L has a market cap of 221B. Regarding current trading prices, 0R1F.L is priced at £72.70, while 0QCV.L trades at £146.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
0R1F.L currently has a P/E ratio of 25.75, whereas 0QCV.L's P/E ratio is 21.08. In terms of profitability, 0R1F.L's ROE is +0.27%, compared to 0QCV.L's ROE of +0.34%. Regarding short-term risk, 0R1F.L is less volatile compared to 0QCV.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0R1F.L.Check 0QCV.L's competition here